MoneyWorks4Me

Zydus Lifesciences informs about press release

06 Nov 2025 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated November 6, 2025, titled ‘Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of betathalassemia’.

The above information is a part of company’s filings submitted to BSE.  
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..